Sintx Technologies (SINT) EBT Growth (1y) (2014 - 2026)
Sintx Technologies (SINT) EBT Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 74.66% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 103.34% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -27.02% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | -23.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.08% |
| Dec 31, 2025 | -30.68% |
| Sep 30, 2025 | 43.28% |
| Jun 30, 2025 | -5.17% |
| Mar 31, 2025 | -158.69% |
| Dec 31, 2024 | 26.97% |
| Sep 30, 2024 | -95.58% |
| Jun 30, 2024 | 10.22% |
| Mar 31, 2024 | -202.39% |
| Dec 31, 2023 | 41.36% |
| Sep 30, 2023 | -17.11% |
| Jun 30, 2023 | 2.27% |
| Mar 31, 2023 | 89.70% |
| Dec 31, 2022 | -85.47% |
| Sep 30, 2022 | -16.26% |
| Jun 30, 2022 | -14.23% |
| Mar 31, 2022 | -8.05% |
| Dec 31, 2021 | -23.21% |
| Sep 30, 2021 | 3.90% |
| Jun 30, 2021 | 45.41% |